Literature DB >> 23478996

Loop C and the mechanism of acetylcholine receptor-channel gating.

Prasad Purohit1, Anthony Auerbach.   

Abstract

Agonist molecules at the two neuromuscular acetylcholine (ACh) receptor (AChR) transmitter-binding sites increase the probability of channel opening. In one hypothesis for AChR activation ("priming"), the capping of loop C at each binding site transfers energy independently to the distant gate over a discrete structural pathway. We used single-channel analyses to examine the experimental support for this proposal with regard to brief unliganded openings, the effects of loop-C modifications, the effects of mutations to residues either on or off the putative pathway, and state models for describing currents at low [ACh]. The results show that (a) diliganded and brief unliganded openings are generated by the same essential, global transition; (b) the radical manipulation of loop C does not prevent channel opening but impairs agonist binding; (c) both on- and off-pathway mutations alter gating by changing the relative stability of the open-channel conformation by local interactions rather than by perturbing a specific site-gate communication link; and (d) it is possible to estimate directly the rate constants for agonist dissociation from and association to both the low and high affinity forms of the AChR-binding site by using a cyclic kinetic model. We conclude that the mechanism of energy transfer between the binding sites and the gate remains an open question.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478996      PMCID: PMC3607824          DOI: 10.1085/jgp.201210946

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  50 in total

1.  Conformational dynamics of the alphaM3 transmembrane helix during acetylcholine receptor channel gating.

Authors:  David J Cadugan; Anthony Auerbach
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

2.  Energy and structure of the M2 helix in acetylcholine receptor-channel gating.

Authors:  Archana Jha; Prasad Purohit; Anthony Auerbach
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

Review 3.  The gating isomerization of neuromuscular acetylcholine receptors.

Authors:  Anthony Auerbach
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

4.  Temperature dependence of acetylcholine receptor channels activated by different agonists.

Authors:  Shaweta Gupta; Anthony Auerbach
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

5.  Energetics of gating at the apo-acetylcholine receptor transmitter binding site.

Authors:  Prasad Purohit; Anthony Auerbach
Journal:  J Gen Physiol       Date:  2010-04       Impact factor: 4.086

6.  Isomerization of the proline in the M2-M3 linker is not required for activation of the human 5-HT3A receptor.

Authors:  Isabelle M Paulsen; Ian L Martin; Susan M J Dunn
Journal:  J Neurochem       Date:  2009-05-18       Impact factor: 5.372

7.  Detection and trapping of intermediate states priming nicotinic receptor channel opening.

Authors:  Nuriya Mukhtasimova; Won Yong Lee; Hai-Long Wang; Steven M Sine
Journal:  Nature       Date:  2009-04-01       Impact factor: 49.962

8.  Acetylcholine receptor gating at extracellular transmembrane domain interface: the "pre-M1" linker.

Authors:  Prasad Purohit; Anthony Auerbach
Journal:  J Gen Physiol       Date:  2007-12       Impact factor: 4.086

9.  Gating at the mouth of the acetylcholine receptor channel: energetic consequences of mutations in the alphaM2-cap.

Authors:  Pallavi A Bafna; Prasad G Purohit; Anthony Auerbach
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

10.  Nicotinic receptor interloop proline anchors beta1-beta2 and Cys loops in coupling agonist binding to channel gating.

Authors:  Won Yong Lee; Chris R Free; Steven M Sine
Journal:  J Gen Physiol       Date:  2008-08       Impact factor: 4.086

View more
  33 in total

1.  Study, by use of coarse-grained models, of the functionally crucial residues and allosteric pathway of anesthetic regulation of the Gloeobacter violaceus ligand-gated ion channel.

Authors:  Xing Yuan Li; Fang Xie; Jing Chao Zhang; Ji Guo Su
Journal:  Eur Biophys J       Date:  2014-11-04       Impact factor: 1.733

2.  Dose-Response Analysis When There Is a Correlation between Affinity and Efficacy.

Authors:  Anthony Auerbach
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

3.  Function of the M1 π-helix in endplate receptor activation and desensitization.

Authors:  Prasad Purohit; Srirupa Chakraborty; Anthony Auerbach
Journal:  J Physiol       Date:  2015-06-04       Impact factor: 5.182

4.  Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity.

Authors:  Christine L Dixon; Neil L Harrison; Joseph W Lynch; Angelo Keramidas
Journal:  Br J Pharmacol       Date:  2015-05-11       Impact factor: 8.739

5.  Don't flip out: AChRs are primed to catch and hold your attention.

Authors:  Andrew J R Plested
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

6.  Catch-and-hold activation of muscle acetylcholine receptors having transmitter binding site mutations.

Authors:  Prasad Purohit; Iva Bruhova; Shaweta Gupta; Anthony Auerbach
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

Review 7.  Structural mechanisms of activation and desensitization in neurotransmitter-gated ion channels.

Authors:  Andrew J R Plested
Journal:  Nat Struct Mol Biol       Date:  2016-06-07       Impact factor: 15.369

8.  Cyclic activation of endplate acetylcholine receptors.

Authors:  Tapan K Nayak; Anthony Auerbach
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-23       Impact factor: 11.205

9.  Molecular recognition at cholinergic synapses: acetylcholine versus choline.

Authors:  Iva Bruhova; Anthony Auerbach
Journal:  J Physiol       Date:  2016-12-12       Impact factor: 5.182

Review 10.  Agonist activation of a nicotinic acetylcholine receptor.

Authors:  Anthony Auerbach
Journal:  Neuropharmacology       Date:  2014-10-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.